BridgeMD
Compares treatment options for Anemia
Official title Efficacy and Tolerability of Sucrosomial® Iron vs Ferric Maltol in Iron Deficient Women
ClinicalTrials.gov ID: NCT07308769
What this study is testing
What is Ferric Maltol (Feraccru®)?
Ferric Maltol (Feraccru®) is an investigational medicine, given as a pill taken by mouth, being studied as a potential treatment for anemia.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- This study aims to compare two oral iron treatments, Sucrosomial® Iron and Ferric Maltol, in women with mild to moderate iron deficiency anemia. Many patients experience gastrointestinal side effects or poor tolerability with traditional iron supplements, which may limit adherence.
- Phase 4: studies an already-approved treatment
- Time commitment: about 12 weeks
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older, women only
You may be able to join if
- Female participants ≥ 18 years
- Mild anemia (11.0 ≤ Hb \< 12 g/dL) or moderate anemia (8.0 \< Hb \< 11 g/dL)
- Signed informed consent
You likely can't join if
- Use of iron-containing drugs or supplements within 1 month prior to screening
- Psychiatric disorders interfering with consent or compliance
- Active cancer (except fibroids and polyps)
- Pregnant or breastfeeding women
- Participation in another treatment study
- History of poor adherence or inability to comply
See the full eligibility criteria
- Female participants ≥ 18 years
- Mild anemia (11.0 ≤ Hb \< 12 g/dL) or moderate anemia (8.0 \< Hb \< 11 g/dL)
- Signed informed consent
- Use of iron-containing drugs or supplements within 1 month prior to screening
- Psychiatric disorders interfering with consent or compliance
- Active cancer (except fibroids and polyps)
- Pregnant or breastfeeding women
- Participation in another treatment study
- History of poor adherence or inability to comply
- Use of erythropoietin within 3 months prior to screening
- Need for blood transfusion or IV iron (per investigator judgment)
- Severe active IBD (HBI \> 16 for Crohn; CAI \> 12 for ulcerative colitis)
- Previous bariatric surgery
- Alcohol abuse
- Hemochromatosis or iron overload syndromes
- Hereditary anemias (including thalassemia)
- Known hypersensitivity to study product ingredients
The study team makes the final eligibility decision.
Where it's taking place
- Barcelona, Spain
- Málaga, Spain
- Sant Cugat del Vallès, Spain
- Zaragoza, Spain
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The study runs about 12 weeks per participant, based on its public description. The team confirms the exact schedule and number of visits before you enroll.
Who can join this trial?
This study is enrolling female, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Barcelona, Spain; Málaga, Spain; Sant Cugat del Vallès, Spain; Zaragoza, Spain. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.